晚期胃癌中Ki-67、PCNA和MCM2蛋白增殖指数(PI)的免疫组织化学评估

Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.

作者信息

Czyzewska Jolanta, Guzińska-Ustymowicz Katarzyna, Pryczynicz Anna, Kemona Andrzej, Bandurski Roman

机构信息

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland.

出版信息

Folia Histochem Cytobiol. 2009;47(2):289-96. doi: 10.2478/v10042-009-0042-y.

Abstract

The current study objective was to assess the proliferation indices (PI) of Ki-67, PCNA and MCM2 proteins in advanced gastric cancer and in metastatic lymph node in correlation with certain clinicopathological features and with postoperative survival of patients. The study was conducted in a group of 100 patients with advanced gastric cancers. Involvement of local lymph nodes was present in 36 cases. Immunohistochemical investigations were carried out using monoclonal antibodies against Ki-67 (DAKO), PCNA (DAKO) and polyclonal antibody to MCM2 (Santa Cruz Biotechnology). Visualization of the antigen/antibody complex was performed using LSAB technique (biotin-streptavidin-peroxidase) followed by application of chromogene DAB (DAKO). Statistical analysis revealed no correlations of Ki-67, PCNA and MCM2 PI in tumour tissue or metastatic lymph node with patients' age and gender, tumour location, histological grade, macroscopic type according to Bormann's classification and histological grading by Lauren's and Goseki's classifications. Moreover, no correlation was observed of Ki-67 and MCM2 PI in tumour tissue with histological grading. No correlation was also noted between the proliferation indices of all the three proteins in the affected lymph node and grade of histological differentiation. Such clinicopathological parameters as patients' age and gender, histological grading by Lauren's and Goseki's classifications and lymph node involvement did not correlate with survival time of patients. Furthermore, no statistically significant correlation was shown of postoperative survival time with Ki-67 and MCM2 PI in tumour tissue and metastatic lymph nodes and with PCNA PI in the affected lymph nodes. However, a statistically significant correlation was found of Ki-67, PCNA and MCM2 PI in tumour tissue and metastatic lymph nodes with depth of wall invasion and local lymph node involvement. A statistically significant correlation was also noted between PCNA PI in the main mass of tumour and histological grading. The postoperative survival time of patients exhibited a statistically significant correlation with tumour location and macroscopic type according to Bormann's classification. Correlations on statistical borderline were noted between survival time and depth of gastric wall invasion and PCNA PI in the main mass of tumour.

摘要

本研究的目的是评估晚期胃癌及转移淋巴结中Ki-67、增殖细胞核抗原(PCNA)和微小染色体维持蛋白2(MCM2)的增殖指数(PI),并分析其与某些临床病理特征及患者术后生存率的相关性。本研究纳入了100例晚期胃癌患者。其中36例存在局部淋巴结转移。采用抗Ki-67(DAKO)、PCNA(DAKO)的单克隆抗体及抗MCM2的多克隆抗体(圣克鲁斯生物技术公司)进行免疫组织化学研究。使用链霉亲和素-生物素-过氧化物酶(LSAB)技术,随后应用显色剂3,3'-二氨基联苯胺(DAB,DAKO)对抗原/抗体复合物进行可视化。统计分析显示,肿瘤组织或转移淋巴结中的Ki-67、PCNA和MCM2增殖指数与患者年龄、性别、肿瘤位置、组织学分级、根据博尔曼分类法的大体类型以及劳伦和越木分类法的组织学分级均无相关性。此外,肿瘤组织中Ki-67和MCM2增殖指数与组织学分级也无相关性。受累淋巴结中所有三种蛋白的增殖指数与组织学分化程度之间也无相关性。患者年龄、性别、劳伦和越木分类法的组织学分级以及淋巴结受累情况等临床病理参数与患者生存时间无关。此外,术后生存时间与肿瘤组织和转移淋巴结中的Ki-67和MCM2增殖指数以及受累淋巴结中的PCNA增殖指数均无统计学显著相关性。然而,发现肿瘤组织和转移淋巴结中的Ki-67、PCNA和MCM2增殖指数与壁浸润深度和局部淋巴结受累情况存在统计学显著相关性。肿瘤主体中的PCNA增殖指数与组织学分级之间也存在统计学显著相关性。患者的术后生存时间与肿瘤位置及根据博尔曼分类法的大体类型存在统计学显著相关性。生存时间与胃壁浸润深度及肿瘤主体中的PCNA增殖指数之间存在统计学临界相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索